Bottom line
Is XHS a good fund? The bottom line
XHS is an index health care sector ETF from SPDR (State Street).
Annual fees run 0.35% — about $35 a year on every $10,000 invested, cheaper than 91% of health care sector funds we track.
It returned +18.7% over one year, +2.3% a year over five years, +6.9% a year over ten (as of Dec 31, 2025, per its prospectus).
With $140 million in net assets and 65 holdings, its largest position is LifeStance Health Group Inc (2.2%) and the top 10 make up 20.4% of the portfolio.
What stands out
- Low cost: cheaper than 91% of health care sector peers
What to watch
- 5-year return in the bottom quarter of its category
Updated Nov 19, 2026
What XHS invests in
The State Street SPDR S&P Health Care Services ETF (the Fund) seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the health care providers and services segment of a U.S. total market composite index.
In seeking to track the performance of the S&P Health Care Services Select Industry Index ? (the Index), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. Instead, the Fund may purchase a subset of the securities in the Index in an effort to hold a portfolio of securities with generally the same risk and return characteristics of the Index. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. Based on its analysis of these factors, SSGA Funds Management, Inc. (SSGA FM or the Adviser), the investment adviser to the Fund, either may invest the Fund's assets in a subset of securities in the Index or may invest the Fund's assets in substantially all of the securities represented in the Index in approximately the same proportions as the Index, as…
From the fund's prospectus (filed Oct 26, 2026).
XHS performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| XHS | +18.7% | +2.3% | +6.9% |
| Health Care Sector median | +14.5% | +4.2% | +7.9% |
Source: Fund prospectus, as of Dec 31, 2025
What XHS costs
On a $10,000 investment, XHS's 0.35% expense ratio costs about $35 a year. The prospectus estimates $443 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.
XHS top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | LifeStance Health Group Inc | 2.20% |
| 2 | Hinge Health Inc | 2.16% |
| 3 | NeoGenomics Inc | 2.09% |
| 4 | GeneDx Holdings Corp | 2.04% |
| 5 | Hims & Hers Health Inc | 2.02% |
| 6 | PACS Group Inc | 2.01% |
| 7 | Acadia Healthcare Co Inc | 2.00% |
| 8 | Brookdale Senior Living Inc | 1.98% |
| 9 | Astrana Health Inc | 1.94% |
| 10 | Surgery Partners Inc | 1.91% |
Source: SEC Form N-PORT, period ended Jun 30, 2026
The top 10 make up 20.4% of the fund. See all top 25 holdings and asset mix →